On September 10, 2018, a tiny Cambridge biotech firm won a patent on a breakthrough treatment that can “Cut & Paste” disease from your body.
Click here to learn about this small, under-the-radar company >>>
The Nobel Prize Committee is calling it “The Holy Grail of Medicine”
The Wall Street Journal reports the company is “transforming medicine.”
60 Minutes reports the company is “revolutionizing the search for new drugs.”
Get the name of this tiny biotech here >>>
That’s why the biggest drug companies have rushed to invest over a $1 billion in this breakthrough —
• Juno Pharma invested $700 million.
• Glaxo SmithKline invested $350 million.
• Johnson and Johnson invested $292 million.
That’s on top of the $120 million Bill Gates and Google Ventures already invested into this firm.
The list goes on and on…
Never before has so much money invested in a new treatment so quickly.
Investor’s Business Daily estimates the market is at least a $75 billion market.
But the leading company in the space is just a tiny fraction of that size.
Click here to learn more about this rare opportunity>>>
